News

The outcomes of patients with idiopathic pulmonary fibrosis (IPF) remain unknown. Alongside the global adoption of antifibrotic therapies, there is currently relentless research for biomarkers and ...
A nurse-led intervention had a greater effect on dyspnea among patients with advanced lung cancer who experienced improvement in their psychological distress.
Boehringer Ingelheim unveiled new data from its top oncology prospect zongertinib, further backing the drug’s prowess in ...
Scientists have discovered that a rare immune cell type in the lungs, called NAMs, plays a crucial role in surviving COVID-19 ...
People with diseases caused by rare mutations have fewer options and poorer prospects than other patients despite rapid ...
The discovery broadens the known spectrum of this rare disorder, emphasizing the critical role of collaboration with patient ...
A rare cell type in the lungs is essential to survival from the COVID-19 virus, a new study shows.
A US teenager was recently reported to have developed the oddly named medical condition "popcorn lung" after vaping in secret ...
Louisville continues to struggle with poor air quality, according to a new report, as federal support is eroded.
Louisvillians spend more than a week every year breathing unhealthy air, according to new data from the American Lung ...
Although immunotherapies and biomarker-driven interventions have transformed lung cancer outcomes, Martin Edelman, MD, Fox Chase Cancer Center, highlighted the present challenge hindering clinicians' ...
We’ve known for some time type 2 diabetes causes a range of health complications, like heart disease. But now we ... Biology and Deputy Director, Baker Heart and Diabetes Institute ...